Chalfont, PA, United States of America

Michael C Seidel


Average Co-Inventor Count = 1.5

ph-index = 6

Forward Citations = 95(Granted Patents)


Location History:

  • Levittown, PA (US) (1978)
  • Chalfont, PA (US) (1976 - 2003)

Company Filing History:


Years Active: 1976-2003

Loading Chart...
15 patents (USPTO):Explore Patents

Title: Michael C. Seidel: Pioneering Innovations in Fatty Acid Research

Introduction

Michael C. Seidel, a distinguished inventor based in Chalfont, PA, has made significant contributions to the field of fatty acid research, with a remarkable portfolio of 15 patents. His innovations focus primarily on the suppression and treatment of carcinoma using conjugated fatty acids, showcasing his commitment to advancing medical technology and therapeutic methods.

Latest Patents

Among his latest patents, Seidel has developed groundbreaking methods for the treatment of carcinoma in humans. One patent discloses a procedure that involves administering a therapeutically effective amount of a fatty acid containing four carbon atoms, characterized by specific bonding arrangements. This method includes intricate steps, such as reacting an ester of the fatty acid with tosyl chloride or mesyl chloride to create a highly purified fatty acid.

Additionally, he has patented a method for liquid chromatography aimed at providing a purified conjugated fatty acid. This invention incorporates a novel synthesis process and advanced separation techniques, yielding conjugated fatty acids with purity levels exceeding 90%. The innovative use of liquid chromatography, including strong acid macroreticular ion exchange resin and silver ion liquid chromatography, emphasizes his adeptness in chemical processes.

Career Highlights

Michael C. Seidel has achieved noteworthy recognition throughout his career, particularly during his tenure at Rohm and Haas Company. His work at this prominent corporation highlights his capacity for driving innovation within established industries and underscores his dedication to scientific advancement.

Collaborations

Collaborating with esteemed professionals such as Stanley A. Greenfield and Evan H. Crook has further enhanced Seidel's innovative contributions. Together, they have explored new frontiers in fatty acid research, demonstrating the value of collaboration in scientific endeavors.

Conclusion

In conclusion, Michael C. Seidel stands as a prominent figure in the realm of fatty acid research and carcinoma treatment. His 15 patents reflect his deep commitment to innovation, establishing him as a significant contributor to advancements in medical technology. Through his career and collaborations, Seidel continues to push the boundaries of what is possible in the field, paving the way for future discoveries and innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…